drugset
drugset / Trial / NCT00488449

Study Of Pharmacokinetics and Pharmacodynamics Effects Of GSK256073A On Healthy Volunteers

NCT00488449 ↗

Phase 1 Completed 56 enrolled GlaxoSmithKline
RandomizedParallel-groupSingle-blindDiagnostic

Summary

The purpose of this study is to compare the effects of single and repeat doses of GSK256073 with placebo in HVT subjects.

Timeline

Start
2007-06
Primary completion
2007-11
Completion
2007-11

Drugs

EvaluationDrugModalityDoseRoute
Subject GSK256073A Unknown — Oral

Indications

hyperlipidemia